Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Shares Repurchased (2024 - 2025)

Indivior Pharmaceuticals has reported Shares Repurchased over the past 2 years, most recently at $11.0 million for Q1 2025.

  • Quarterly results put Shares Repurchased at $11.0 million for Q1 2025, down 69.44% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (down 93.64% YoY), and the annual figure for FY2025 was $11.0 million, down 93.64%.
  • Shares Repurchased for Q1 2025 was $11.0 million at Indivior Pharmaceuticals, down from $50.0 million in the prior quarter.
  • Over the last five years, Shares Repurchased for INDV hit a ceiling of $52.0 million in Q3 2024 and a floor of $11.0 million in Q1 2025.